These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22102006)

  • 1. Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.
    Gao C; Pang L; Ren C; Ma T
    Pathol Oncol Res; 2012 Apr; 18(2):471-7. PubMed ID: 22102006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
    Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
    Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
    Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
    Zhang H; Chen W; Duan CJ; Zhang CF
    World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.
    Hao CL; Li Y; Yang HX; Luo RZ; Zhang Y; Zhang MF; Cheng YF; Wang X
    Int J Clin Exp Pathol; 2014; 7(7):4213-21. PubMed ID: 25120801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of RKIP, E-cadherin and NF-kB p65 in esophageal squamous cell carcinoma and their correlations.
    Ping FM; Liu GJ; Liu ZJ; Li HB; Zhai JW; Li SX; Liu YM; Li BW; Wei H
    Int J Clin Exp Pathol; 2015; 8(9):10164-70. PubMed ID: 26617724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases.
    Birner P; Jesch B; Schultheis A; Schoppmann SF
    Clin Exp Metastasis; 2012 Aug; 29(6):551-9. PubMed ID: 22460832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
    Wang Y; Chen JJ; Wang XF; Wang Q
    World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma.
    Wu X; Lim ZF; Li Z; Gu L; Ma W; Zhou Q; Su H; Wang X; Yang X; Zhang Z
    Oncol Res Treat; 2017; 40(6):370-374. PubMed ID: 28482344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
    Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
    Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
    Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?
    Shi M; Wang Z; Song L; Wang D; Sun Z
    Med Oncol; 2014 May; 31(5):951. PubMed ID: 24737010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.
    Wang Q; Zhu H; Xiao Z; Zhang W; Liu X; Zhang X; He J; Sun K; Wang L; Xu N
    World J Surg Oncol; 2013 Oct; 11():278. PubMed ID: 24131756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.
    Hatogai K; Fujii S; Kojima T; Daiko H; Nomura S; Doi T; Kitano S; Ohtsu A; Takiguchi Y; Yoshino T; Ochiai A
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2351-2361. PubMed ID: 28756492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Luo RZ; He LR; He JH; Huang ZL; Zeng MS; Wen ZS
    BMC Surg; 2013 May; 13():15. PubMed ID: 23711283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma.
    Liang Y; Hou X; Cui Q; Kang TB; Fu JH; Zhang LJ; Luo RZ; He JH; Zeng YX; Yang HX
    J Transl Med; 2012 May; 10():73. PubMed ID: 22533738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.